Glycemicon AG Alternatives & Competitors

12 companies similar to Glycemicon AG

Kayothera

Drugging the Undruggable with 1st-in-class RAR/RXR Nuclear Receptor Pathway Inhibitors. EF...

5 Series A $13.95M

Seattle, United States

Biotechnology Health Care

Prometheon Pharma, LLC

2 Convertible Note $1.13M

Gainesville, United State...

Biotechnology Health Care

Carmot Therapeutics, Inc.

Carmot has been acquired by Roche in early 2024, making the company a member of the Roche...

5 Series E $384.85M

Berkeley, United States

Biotechnology Health Care +1

BioKier, Inc.

Pioneering Solutions for Diabetes and Metabolic Health Since 2008

5 Venture round $2.89M

Chapel Hill, United State...

Biotechnology Pharmaceutical

Track all Glycemicon AG competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

EOLO PHARMA

Cutting-Edge Pharmacological Treatment for Obesity

12 Venture round $4.50M

San Francisco, United Sta...

Biopharma Biotechnology +2

Luciole Pharmaceuticals, Inc.

Bringing Energy to Life

Natick, United States

Biotechnology

Alveus Therapeutics Inc

Redefining Weight Management

34 Series A $197.00M

Philadelphia, United Stat...

Biotechnology

DiObex

Innovative biotechnology solutions for metabolic disorders.

Series B $31.08M

Biotechnology Health Care

Aspect Biosystems

Developing Bioprinted Tissue Therapeutics to transform how we treat some of the most elusi...

143 $323.73M

Canada

Biotechnology Life Sciences

Phaim Pharma Ltd

Our vision is to create a world where no one has to live with an autoimmune disease.

London, United Kingdom

Biotechnology

Transgene

Immunotherapy against cancer. 4 clinical-stage products. 2 novel platforms: Invir.IO™ and...

213 Post-IPO Equity $82.50M

Illkirch-graffenstaden, F...

Biotechnology Manufacturing +1

Frequently Asked Questions

Companies similar to Glycemicon AG include Kayothera, Prometheon Pharma, LLC, Carmot Therapeutics, Inc., BioKier, Inc., EOLO PHARMA. They work in Biotechnology.

Bounce Watch lists 12 companies that share Glycemicon AG's industries and are closest to it in business tags, services, target customers, business model and size.

Glycemicon AG is a Swiss biotechnology company that was founded in 2013. The company is focused on developing novel nutraceuticals for managing prediabetes, diabetes, and obesity. Their latest milestone came with a Fr.1.80M Series A investment on 03 April 2018.

Don't just read about them. Follow them.

BounceWatch watches Glycemicon AG and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Glycemicon AG Profile Kayothera Alternatives Carmot Therapeutics, Inc. Alternatives BioKier, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Glycemicon AG on 12 Sep 2024. The 11 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.